NCT05013229: An ongoing trial by Novo Nordisk A/S
This trial is completed, but has been granted a delay in reporting its results.
It must report results 11 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05013229 |
|---|---|
| Title | A 52 Week Study Comparing the Efficacy and Safety of Once Weekly IcoSema and Daily Insulin Glargine 100 Units/mL Combined With Insulin Aspart, Both Treatment Arms With or Without Oral Anti Diabetic Drugs, in Participants With Type 2 Diabetes Inadequately Controlled With Daily Basal Insulin. COMBINE 3 |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 30, 2021 |
| Completion date | Nov. 14, 2023 |
| Required reporting date | Nov. 14, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |